Profusa amends equity facility to lower floor price to $0.111/share, eliminates amortization on convertible note

Profusa, Inc.

SPA Amendment lowers Floor Price to $0.111/share for up to 13.65M shares during Modification Period ending upon reverse stock split (expected Jan 2026).
After modification period, Floor Price reverts to $0.14/share, the original 20% of July 25, 2025 closing price.
Amendment No. 2 to convertible note eliminates monthly amortization payments, reducing near-term cash obligations.
Mandatory prepayment for any future Equity Line of Credit increased from 17.5% to 33.3% of net proceeds.
Both amendments effective Dec 22, 2025; company plans reverse stock split vote in January 2026.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

Profusa, Inc. amended Amendment No. 1 to Securities Purchase Agreement with Ascent Partners Fund LLC valued at aggregate purchase price up to $100,000,000; modified Floor Price $0.111 per share (effective 2025-12-22).

Action: amendment
Agreement: equity purchase
Counterparty: Ascent Partners Fund LLC
Value: aggregate purchase price up to $100,000,000; modified Floor Price $0.111 per share
Effective: 2025-12-22

Exact text from the filing

Amendment No. 1 to Securities Purchase Agreement dated July 28, 2025 As previously disclosed in the prospectus on Form 424B3 filed on October 29, 2025 by Profusa, Inc.

View on SEC.gov

119 material agreements filed in the last 30 days. Browse all material agreements →

Profusa, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-25-124826

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.